A Prospective Study of Combination of Peginterferon Alfa-2b (40kD, Y-shape) and GM-CSF in Chronic Hepatitis B

NCT02332473 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Ypeginterferon alfa-2b
DRUG: Granulocyte-macrophage colony stimulating factor

Sponsor

Xiamen Amoytop Biotech Co., Ltd.

Collaborators

[object Object]